Evidence map›Paper›PMID 38891883›Full record

ArticleInternational journal of molecular sciences2024

Cartilage-Specific Gene Expression and Extracellular Matrix Deposition in the Course of Mesenchymal Stromal Cell Chondrogenic Differentiation in 3D Spheroid Culture.

Igor V Vakhrushev, Yulia B Basok, Konstantin K Baskaev, Victoria D Novikova, Georgy E Leonov, Alexey M Grigoriev, Aleksandra D Belova, Ludmila A Kirsanova, Alexey Y Lupatov, Veronika V Burunova and 4 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Igor V VakhrushevLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.ORCID 0000-0001-9367-6656
Yulia B BasokDepartment for Biomedical Technologies and Tissue Engineering, Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.ORCID 0000-0003-4807-3164
Konstantin K BaskaevLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.ORCID 0000-0003-1437-8656
Victoria D NovikovaLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.ORCID 0009-0006-4502-6898
Georgy E LeonovLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.ORCID 0000-0002-5632-7040
Alexey M GrigorievDepartment for Biomedical Technologies and Tissue Engineering, Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.
Aleksandra D BelovaDepartment for Biomedical Technologies and Tissue Engineering, Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.ORCID 0000-0003-2938-5883
Ludmila A KirsanovaDepartment for Biomedical Technologies and Tissue Engineering, Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.
Alexey Y LupatovLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.
Veronika V BurunovaLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.
Alexey V KovalevPriorov Central Institute for Trauma and Orthopedics, Moscow 127299, Russia.ORCID 0000-0003-1277-5228
Pavel I MakarevichInstitute for Regenerative Medicine, Medical Research and Education Centre, Lomonosov Moscow State University, Moscow 119192, Russia.ORCID 0000-0001-8869-5190
Victor I SevastianovDepartment for Biomedical Technologies and Tissue Engineering, Shumakov National Medical Research Center of Transplantology and Artificial Organs, Moscow 123182, Russia.ORCID 0000-0003-1995-3373
Konstantin N YaryginLaboratory of Cell Biology, Institute of Biomedical Chemistry, Moscow 119121, Russia.ORCID 0000-0002-2261-851X

Funding

This work was financed by the Ministry of Science and Higher Education of the Russian Federation within the framework of state support for the creation and development of World-Class Research Centers 'Digital Biodesign and Personalized Healthcare' (No 075 No 075-15-2022-305
6 · The paper itself

Abstract

Articular cartilage damage still remains a major problem in orthopedical surgery. The development of tissue engineering techniques such as autologous chondrocyte implantation is a promising way to improve clinical outcomes. On the other hand, the clinical application of autologous chondrocytes has considerable limitations. Mesenchymal stromal cells (MSCs) from various tissues have been shown to possess chondrogenic differentiation potential, although to different degrees. In the present study, we assessed the alterations in chondrogenesis-related gene transcription rates and extracellular matrix deposition levels before and after the chondrogenic differentiation of MSCs in a 3D spheroid culture. MSCs were obtained from three different tissues: umbilical cord Wharton's jelly (WJMSC-Wharton's jelly mesenchymal stromal cells), adipose tissue (ATMSC-adipose tissue mesenchymal stromal cells), and the dental pulp of deciduous teeth (SHEDs-stem cells from human exfoliated deciduous teeth). Monolayer MSC cultures served as baseline controls. Newly formed 3D spheroids composed of MSCs previously grown in 2D cultures were precultured for 2 days in growth medium, and then, chondrogenic differentiation was induced by maintaining them in the TGF-β1-containing medium for 21 days. Among the MSC types studied, WJMSCs showed the most similarities with primary chondrocytes in terms of the upregulation of cartilage-specific gene expression. Interestingly, such upregulation occurred to some extent in all 3D spheroids, even prior to the addition of TGF-β1. These results confirm that the potential of Wharton's jelly is on par with adipose tissue as a valuable cell source for cartilage engineering applications as well as for the treatment of osteoarthritis. The 3D spheroid environment on its own acts as a trigger for the chondrogenic differentiation of MSCs.

Indexed as

Cell DifferentiationChondrocytesChondrogenesisExtracellular MatrixMesenchymal Stem CellsSpheroids, CellularAdipose TissueCartilageCell Culture TechniquesCells, CulturedDental PulpHumansTissue EngineeringTooth, DeciduousWharton Jelly3D cell cultureadipose tissuecartilage regenerationchondrogenic differentiationchondrospheresdeciduous teethmesenchymal stromal cellstissue spheroidsumbilical cordWharton’s jelly

Identifiers

PMID38891883
PMCPMC11172056

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.